Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study. Li LL, Wang RZ, Wang Z, Hu H, et al. Brain 2025 Nov 11:awaf427. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li LL, Wang RZ, Wang Z, Hu H, et al. Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study. Brain 2025 Nov 11:awaf427. doi: 10.1093.
PMID: 41215623